NEW genderless connectors® for innovative sterile connections - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

NEW genderless connectors® for innovative sterile connections

New genderless AseptiQuik® G Connectors from Colder Products Company make single-use sterile connections faster, easier and safer than ever before—even in non-sterile conditions.

The genderless design eliminates separate male and female components, allowing any G series connectors to mate together.  This universal “G” mating simplifies systems integration and increases process flexibility for transferring valuable media.

The unique design of AseptiQuik G connectors minimizes the risk of operator error, reduces complexity, labor and inventory requirements. The new G series is available in a full range of interchangeable 1/4” to 3/4” flow solutions, in both gamma and high-temperature versions. Terminations include 1/4” hose barb, 1/2” hose barb, 3/4” hose barb and 3/4” sanitary.

The AseptiQuik family of connectors—in a full range of 1/8” to 1” flow configurations—provides unequalled ease of use and robust construction for reliable, repeatable performance without burdensome assembly aids, clamps or tube welding. AseptiQuik connectors are ideal for single-use bag and tubing assemblies, bioreactors, mixers, sampling and filling applications.  For applications where reliability and sterility are a must, Connect with Colder.

See how easy connections are with AseptiQuik® G —click here for video.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here